Tom Taulli
Tom Taulli (RSS)
InvestorPlace Writer & IPO Playbook Editor

Read complete bio
Recent Articles

3 Tax Issues You Might Face in Retirement

Feb. 10, 2017, 11:45 am EST – Retirement accounts can help you build a lot of wealth, but there are a few tax issues you might have to navigate along the way. More 

5 Income Tax Deductions You Can’t Afford to Miss

Feb. 10, 2017, 11:45 am EST – If you're not maximizing your income tax deductions, you're just hurting yourself. Here are five deductions that should be on your radar. More 

5 Ways to Avoid an IRS Tax Audit

Feb. 10, 2017, 11:45 am EST – Audits are definitely time-consuming and expensive. Yet there are some strategies you can take to help avoid being a target. And the good news is that they are fairly simple. More 

Required Minimum Distributions (RMDs): Everything You Need to Know

Feb. 10, 2017, 11:45 am EST – Required minimum distributions (RMDs) are the IRS' way of saying "you can't take it with you." And the penalties for not listening are steep. More 

Capital Gains Tax: What Do You Owe This Year?

Feb. 10, 2017, 11:45 am EST – The capital gains tax is a pretty good deal for investors. You just need to do some planning and remember that timing is everything. More 

Tax E-Filing: What Option Is Best for You?

Feb. 10, 2017, 11:45 am EST – Tax e-filing is increasingly popular, but there's an increasingly wide menu of options to choose from. Here's what you should know. More 

Twitter Inc (TWTR) Stock: No Trump Bailout in Q4

Feb. 9, 2017, 10:14 am EST – Twitter (TWTR) failed to turn a hot election season into anything meaningful in Q4 earnings, and TWTR stock is feeling the pain. More 

Why Fitbit Inc (FIT) Needs to Wise Up Before It Can Win Again

Feb. 9, 2017, 6:30 am EST – Fitbit stock isn't Wall Street's darling anymore, as nothing seems to be working. Then again, FIT faces serious issues with its core business. More 

Twitter Inc (TWTR) Stock May Get Snapped After Earnings

Feb. 7, 2017, 1:43 pm EST – Twitter stock has been horrible for investors lately, and with the Snap IPO on the horizon, things may get even worse for TWTR. More 

Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons

Feb. 7, 2017, 12:45 pm EST – VRX stock is a disaster. Although new management is making moves to fix this, it'll take a long time for Valeant Pharmaceuticals to come back. More